Insight and Predictions: Shedding Light on the Future Use of Open Payments Data
Washington, DC, August 15, 2016 – MMIS, Inc. creator of the award winning MediSpend Global Compliance Platform, announced today that MMIS President and CEO, Michaeline Daboul, will join legal and compliance professionals from CMS, EFPIA, Johnson & Johnson, and AstraZeneca at the event, and will present case studies on how open payments data and analytics are being used by industry regulators and manufactures on Tuesday, August 16th at 9:45am.
Ms. Daboul’s session, at CBI’s 10th Annual Forum on Transparency and Aggregate Spend held in Washington, D.C. August 15 -17, 2016, at 9:45am on Tuesday is titled: Insight and Predictions: Shedding Light on the Future Use of Open Payments Data. This session will focus on the use of the data published by CMS (Center for Medicare & Medicaid Services) Open Payments Program.
Over 28 million records capturing nearly $17 billion dollars of payments and transfers of value to physicians and teaching hospitals have been reported by life science companies since the Open Payments reporting program began in 2013. This public data set provides patients, industry manufactures, private watch dog groups, and government agencies with a unique opportunity to perform detailed analyses and view trends in spending by pharmaceutical and medical device manufacturers.
Ms. Daboul is an industry expert and will speak to best practices in compliance monitoring, competitive analysis and benchmarking by leveraging Open Payments and other publicly available data sources.
“Leveraging data to improve business operations and monitoring to ensure compliance with internal and external policies and codes of conduct is critical for every manager and executive within the organization.” says Ms. Daboul. “Leveraging the data that is collected on a daily basis, and using it to analyze business practices is becoming the industry standard. Companies now have the tools to monitor and manage their internal business practices, while also utilizing the data to benchmark their activities to those of its competitors.”
Ms. Daboul has been interviewed by Inside CMS, CIO Review, Healthcare Finance News, Mass Device and Healthcare Review North East Network on compliance challenges and the importance of implementing a global compliance process. By introducing disruptive technologies to the compliance market, MediSpend has transformed the way companies manage and analyze data with easy to use cloud based tools. “As a proud sponsor of this important conference, we have meetings scheduled with over 40 manufacturers who want to learn how to use MediSpend to move from reactive to proactive transparent compliance program.” Stated Daboul. “We continue to help companies make the transition from manual or first generation systems to fully integrated workflows which save money, time and provide access to better data.”
MMIS is an award winning global technology company, providing innovative compliance and business intelligence solutions for the life science industry. MMIS is the leader who disrupted the compliance market by introducing the MediSpend Global Compliance Platform, delivering cloud-based SaaS solutions to help companies manage HCP relationships from engagement through compliant state, federal and global reporting.
Recently chosen for the second year in a row by CIO Review for its annual listing of the 20 Most Promising Pharma and Life Science Technology Solution Providers, MediSpend provides the first end-to-end global compliance and data analytics SaaS solution. MediSpend continues to lead in innovation, product excellence and customer success.
(888) 731-7322 x9708